alt account for @evanjaka
Montreal, Quebec
Joined March 2010
- Tweets298
- Following229
- Followers126
- Likes2.8K
Emil ".mil" Vanjaka retweeted
Big day! Pleased to announce publication of new data describing the mechanism of action of UM171, the molecule that forms the basis of our ECT-001 Cell Therapy!
excellthera.com/press_releas…
Emil ".mil" Vanjaka retweeted
Cancer claims the lives of over 80,000 Canadians a year.
@Excellthera is an innovative #Montreal company revolutionizing cancer treatment.
Proud to announce with Min @melaniejoly that our federal govt is investing to accelerate their development and growth !
#cdnpoli
Emil ".mil" Vanjaka retweeted
Annonce porteuse d’espoir ce matin avec @RachelBendayan. La société de médecine cellulaire & moléculaire @Excellthera reçoit 4M$ pour accroître leur production, sauver encore plus de vies et créer jusqu’à 150 emplois à #Mtl.🙏On renforce notre indépendance en #SciencesdelaVie. 🇨🇦
Emil ".mil" Vanjaka retweeted
Une raison de célébrer! On a reçu la classification de produit médicinal de thérapie avancée de @EMA_News pour la thérapie cellulaire ECT-001 excellthera.com/press_releas…
Emil ".mil" Vanjaka retweeted
Suis à nouveau à la recherche de personnes pour se joindre à des conseils d'administration de startups comme membres indépendant-es. Si ça vous intéresse faites moi signe par message privé ou courriel à mon prénom @realventures.com.
Exp sur des CAs similaires un atout important.
Emil ".mil" Vanjaka retweeted
Latest data from our study, showing rapid & robust immune recovery in patients transplanted with ECT-001 Cell Therapy, was selected as Best Abstract for oral presentation @CordBloodAssn annual meeting! excellthera.com/press_releas…
Emil ".mil" Vanjaka retweeted
We have strengthened our leadership yet again! Pleased to welcome Richard Cherney to our Board of Directors. excellthera.com/press_releas…
Emil ".mil" Vanjaka retweeted
Of the 20 engineers on staff at CCRM, 13 are women. Happy #WomenInEngineeringDay to them and the other women engineers around the world breaking down barriers and building bridges - literally.
Emil ".mil" Vanjaka retweeted
Our lead solution, ECT-001 Cell Therapy has been granted orphan medicinal product designation by @EMA_News for treatment in haematopoietic stem cell transplantation. excellthera.com/excellthera-…
I'm helping out a local esports business get up and running. Anything helps, big or small! gofundme.com/f/pkmxw-help-bu…
Emil ".mil" Vanjaka retweeted
Big news today: a "miracle" in blood stem-cell transplantation, thanks to the #UM171 molecule. nouvelles.umontreal.ca/en/ar…
Une molécule miracle. Un bel aperçu de nos progrès.
ici.radio-canada.ca/tele/le-…
Emil ".mil" Vanjaka retweeted
We are pleased to announce a publication in The Lancet Haematology highlighting excellent clinical results of
ECT-001 in patients with haematological malignancies excellthera.com/excellthera-…
Emil ".mil" Vanjaka retweeted
ExCellThera annonce la publication dans The Lancet Haematology d’excellents résultats cliniques résultant de l’utilisation d’ECT-001 chez les patients atteints de maladies hématologiques malignes @IRIC_umontreal @UMontreal excellthera.com/fr/excellthe…
Emil ".mil" Vanjaka retweeted
See what's developing at ExCellThera. You can now watch our company presentation by Guy Sauvageau, Founder and CEO at the 2019 Cell & Gene Meeting on the Mesa. #Mesa19 youtube.com/watch?v=z_sFab_j… @alliancerm
Emil ".mil" Vanjaka retweeted
Our phase II clinical trial using ECT-001 for high risk leukemia/myelodysplasia in collaboration with Fred Hutchinson Cancer Research Center in Seattle is now recruiting patients. Full trial details: clinicaltrials.gov/ct2/show/…
Emil ".mil" Vanjaka retweeted
Nous sommes fiers de continuer de supporter notre société en portefeuille @classcraftgame dans sa transformation du monde de l’education! 👩🎓👨🎓 Rendez-vous sur @la_lesaffaires pour en savoir plus sur leur dernier financement:
lesaffaires.com/strategie-d-…
Emil ".mil" Vanjaka retweeted
Join our President and CEO, Guy Sauvageau, live or via webcast as he presents a company update at the Meeting on the Mesa on October 2 #Mesa19 excellthera.com/excellthera-…
Emil ".mil" Vanjaka retweeted
Great report! Nice to see our lead technology's RMAT designation included as a significant event for the quarter.
Our Q2 2019 sector report is now available, detailing industry-specific stats compiled from 932 #celltherapy #genetherapy #tissueengineering & other #regenmed therapeutic developers worldwide, plus commentary from @AveXisInc & @bluebirdbio
Report here: alliancerm.org/?smd_process_…
